TNSN94078A1 - Nouvelle formule pharmaceutique - Google Patents
Nouvelle formule pharmaceutiqueInfo
- Publication number
- TNSN94078A1 TNSN94078A1 TNTNSN94078A TNSN94078A TNSN94078A1 TN SN94078 A1 TNSN94078 A1 TN SN94078A1 TN TNSN94078 A TNTNSN94078 A TN TNSN94078A TN SN94078 A TNSN94078 A TN SN94078A TN SN94078 A1 TNSN94078 A1 TN SN94078A1
- Authority
- TN
- Tunisia
- Prior art keywords
- new pharmaceutical
- formula
- pharmaceutical formula
- new
- omeprazole
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960000381 omeprazole Drugs 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
UNE NOUVELLE FORMULE PHARMACEUTIQUE ORALE CONTENANT UNE NOUVELLE FORME PHYSIQUE D'UN SEL DE MAGNESIUM D'OMEPRAZOLE, UNE METHODE POUR LA FABRICATION D'UNE TELLE FORMULE, ET L'UTILISATION DE TELLE FORMULE EN MEDECINE
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE19939302395A SE9302395D0 (sv) | 1993-07-09 | 1993-07-09 | New pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN94078A1 true TNSN94078A1 (fr) | 1995-04-25 |
Family
ID=20390587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN94078A TNSN94078A1 (fr) | 1993-07-09 | 1994-07-08 | Nouvelle formule pharmaceutique |
Country Status (40)
Country | Link |
---|---|
US (1) | US5690960A (fr) |
EP (1) | EP0706378B1 (fr) |
JP (1) | JP3665334B2 (fr) |
KR (1) | KR100350203B1 (fr) |
CN (1) | CN1126946A (fr) |
AT (1) | ATE231719T1 (fr) |
AU (1) | AU681686B2 (fr) |
BR (1) | BR9406941A (fr) |
CA (1) | CA2166483C (fr) |
CZ (1) | CZ290323B6 (fr) |
DE (1) | DE69432076T2 (fr) |
DK (1) | DK0706378T3 (fr) |
DZ (1) | DZ1794A1 (fr) |
EE (1) | EE03148B1 (fr) |
EG (1) | EG22373A (fr) |
ES (1) | ES2191682T3 (fr) |
FI (1) | FI114008B (fr) |
HK (1) | HK1008299A1 (fr) |
HR (1) | HRP940386B1 (fr) |
HU (1) | HU226779B1 (fr) |
IL (1) | IL110189A0 (fr) |
IS (1) | IS2034B (fr) |
LV (1) | LV13140B (fr) |
MA (1) | MA23258A1 (fr) |
MX (1) | MX9405219A (fr) |
MY (1) | MY128809A (fr) |
NO (1) | NO315146B1 (fr) |
NZ (1) | NZ268694A (fr) |
PL (1) | PL175210B1 (fr) |
RU (1) | RU2138254C9 (fr) |
SA (1) | SA94150057B1 (fr) |
SE (1) | SE9302395D0 (fr) |
SG (1) | SG52365A1 (fr) |
SI (1) | SI0706378T1 (fr) |
SK (1) | SK281105B6 (fr) |
TN (1) | TNSN94078A1 (fr) |
UA (1) | UA43342C2 (fr) |
WO (1) | WO1995001783A1 (fr) |
YU (1) | YU49199B (fr) |
ZA (1) | ZA944934B (fr) |
Families Citing this family (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
MX9600857A (es) * | 1994-07-08 | 1997-06-28 | Astra Ab | Forma de dosificacion i en tabletas, con unidades multiples. |
HUT78132A (hu) * | 1994-07-08 | 2000-06-28 | Astra Aktiebolag | Omeprazol magnéziumsóját tartalmazó új orális gyógyszerforma |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
SE508669C2 (sv) * | 1996-04-26 | 1998-10-26 | Astra Ab | Nytt förfarande |
US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
DE19626045C2 (de) * | 1996-06-28 | 1998-12-03 | Klinge Co Chem Pharm Fab | Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben |
ID21762A (id) * | 1996-09-24 | 1999-07-22 | Lilly Co Eli | Formulasi partikel bersaput |
TW385306B (en) * | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
WO1998050019A1 (fr) * | 1997-05-09 | 1998-11-12 | Sage Pharmaceuticals, Inc. | Formes posologiques pharmaceutiques orales stables |
SE9702000D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Ab | New pharmaceutical formulation |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
US6747155B2 (en) | 1997-05-30 | 2004-06-08 | Astrazeneca Ab | Process |
SI9700186B (sl) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
US20050244497A1 (en) * | 1997-11-05 | 2005-11-03 | Wockhardt Limited | Delayed delivery system for acid-sensitive drugs |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
AU1671799A (en) * | 1997-11-28 | 1999-06-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Medicament preparation in the form of a tablet or pellet for acid-labile active substances |
SE9704870D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
CA2298823C (fr) * | 1998-04-20 | 2011-06-07 | Eisai Co., Ltd. | Composition stabilisee comprenant un compose de type benzimidazole |
UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
US7094426B2 (en) * | 1998-08-27 | 2006-08-22 | Sage Pharmaceuticals, Inc. | Stable oral pharmaceutical dosage forms |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
SE9803772D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
IL142703A (en) * | 1998-11-10 | 2006-04-10 | Astrazeneca Ab | Crystalline form of omeprazole |
UA72748C2 (en) * | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
IL142629A0 (en) | 1998-11-18 | 2002-03-10 | Astra Ab | Improved chemical process and pharmaceutical formulation |
US6365128B1 (en) * | 1998-12-18 | 2002-04-02 | Medical Defence Technologies, Llc | Monitoring gastrointestinal function to guide care of high risk patients |
MXPA01009934A (es) * | 1999-03-29 | 2002-06-21 | American Home Prod | Sistema de recubrimiento. |
IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
SE9902386D0 (sv) * | 1999-06-22 | 1999-06-22 | Astra Ab | New formulation |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US6500459B1 (en) * | 1999-07-21 | 2002-12-31 | Harinderpal Chhabra | Controlled onset and sustained release dosage forms and the preparation thereof |
US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
CA2387746C (fr) | 1999-10-20 | 2010-06-29 | Koji Ukai | Procede de stabilisation de composes a base de benzimidazoles |
CA2409258A1 (fr) * | 2000-05-15 | 2001-11-22 | Ranbaxy Laboratories Limited | Forme amorphe de sels d'omeprazole |
ES2191521B1 (es) * | 2000-11-22 | 2005-02-16 | Laboratorios Belmac, S.A. | Nueva formulacion galenica del omeprazol en forma de comprimidos, procedimiento para su preparacion y aplicaciones en medicina humana y en veterinaria. |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
CN100562317C (zh) * | 2001-10-17 | 2009-11-25 | 武田药品工业株式会社 | 含大量酸不稳定药物的颗粒 |
JP2005521662A (ja) * | 2002-01-25 | 2005-07-21 | サンタラス インコーポレイティッド | プロトンポンプ阻害剤の経粘膜送達 |
WO2003075825A2 (fr) * | 2002-03-08 | 2003-09-18 | Modi, Rajiv, Indravadan | Procede applicable au traitement de la tuberculose |
JP2005536527A (ja) * | 2002-08-02 | 2005-12-02 | ラティオファルム ゲー・エム・ベー・ハー | 微結晶セルロースと混合したベンズイミダゾール化合物を含有する医薬製剤およびその製造方法 |
US7429619B2 (en) | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
AU2003900096A0 (en) * | 2003-01-10 | 2003-02-20 | Nature Vet | Orally deliverable pharmaceutical composition protein pump inhibitors |
ITMI20030616A1 (it) * | 2003-03-28 | 2004-09-29 | Acme Drugs S R L | Metodo per la preparazione di farmaci, alimenti, integratori alimentari, gastroprotetti e/o a rilascio controllato, prodotti dietetici, premiscele per mangim,i additivi per l'alimentazione zootecnica contenenti principi attivi sensibili all'ambiente |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
AR045068A1 (es) * | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
WO2005020954A2 (fr) * | 2003-09-03 | 2005-03-10 | Agi Therapeutics Limited | Formulations inhibitrices de pompe a proton, et procedes d'elaboration et d'utilisation correspondantes |
US20050214388A1 (en) * | 2004-02-18 | 2005-09-29 | Gorham Thomas R | Multivitamin formulations containing controlled-release magnesium |
WO2005082888A1 (fr) * | 2004-03-01 | 2005-09-09 | Milen Merkez Ilac Endustrisi A.S. | Procede de preparation d'un sel magnesique d'omeprazole |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1768668A2 (fr) | 2004-06-16 | 2007-04-04 | Tap Pharmaceutical Products, Inc. | Forme posologique a doses ppi multiples |
US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US8658216B2 (en) | 2004-12-23 | 2014-02-25 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and process of preparation thereof |
US20080279951A1 (en) * | 2005-02-02 | 2008-11-13 | Rajesh Gandhi | Stable Oral Benzimidazole Compositions Prepared by Non-Aqueous Layering Process |
CA2784881C (fr) | 2005-02-25 | 2016-02-09 | Takeda Pharmaceutical Company Limited | Procede de fabrication de granules |
AU2006299424A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties |
WO2007138606A2 (fr) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Formulation pharmaceutique comprenant des unités multiples |
WO2008014175A2 (fr) * | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Ltd. | Compositions pharmaceutiques granulaires |
WO2008067037A2 (fr) | 2006-10-05 | 2008-06-05 | Santarus, Inc. | Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations |
EP2086543A2 (fr) | 2006-10-27 | 2009-08-12 | The Curators of the University of Missouri | Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
WO2009113090A2 (fr) * | 2008-01-17 | 2009-09-17 | Alkem Laboratories Ltd. | Procédé de préparation d’une formule orale d’un médicament à base de benzimidazole sensible à l’acide |
JP2011512416A (ja) | 2008-02-20 | 2011-04-21 | ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ | オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法 |
US8911787B2 (en) | 2008-02-26 | 2014-12-16 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and process of preparation thereof |
EP2293782B1 (fr) * | 2008-05-06 | 2015-08-12 | Dexcel Pharma Technologies Ltd. | Formule stable de benzimidazole |
WO2009137648A1 (fr) * | 2008-05-09 | 2009-11-12 | Aptapharma, Inc. | Pastilles multicouches inhibant la pompe à protons |
KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
PT2379063E (pt) * | 2009-01-09 | 2013-05-03 | Forward Pharma As | Formulação farmacêutica compreendendo um ou mais ésteres de ácido fumárico numa matriz de erosão |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
EP2345408A3 (fr) | 2010-01-08 | 2012-02-29 | Dr. Reddy's Laboratories Ltd. | Formulations de médicament labiles acides |
EP3711658A1 (fr) | 2011-06-14 | 2020-09-23 | Gravitas Medical Inc. | Appareil de guidage de soins médicaux sur la base de la détection d'une fonction gastrique |
EP2797600A4 (fr) | 2011-12-28 | 2015-09-16 | Pozen Inc | Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés |
CN103127026B (zh) * | 2013-02-05 | 2017-02-15 | 悦康药业集团有限公司 | 一种奥美拉唑肠溶胶囊及其制备方法 |
CN103735526A (zh) * | 2013-08-08 | 2014-04-23 | 上海海虹实业(集团)巢湖今辰药业有限公司 | 奥美拉唑镁肠溶片及其制作方法 |
CN103467453A (zh) * | 2013-09-13 | 2013-12-25 | 上海海虹实业(集团)巢湖今辰药业有限公司 | 一种奥美拉唑镁原料药制备方法 |
EP3288556A4 (fr) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Compositions à désintégration par voie orale |
WO2017145146A1 (fr) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprenant des inhibiteurs de la pompe à protons |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CZ2017315A3 (cs) | 2017-06-02 | 2018-12-12 | Zentiva, K.S. | Dávkovací jednotka s PPI (inhibitory protonové pumpy) |
US20230058473A1 (en) | 2020-01-27 | 2023-02-23 | Towa Pharmaceutical Co., Ltd. | Esomeprazole oral preparation and method for producing the same |
US11426353B2 (en) * | 2020-06-24 | 2022-08-30 | 13400719 Canada Inc. | Composite coating for an active agent |
CN113350313B (zh) * | 2021-06-23 | 2023-08-11 | 福建金山生物制药股份有限公司 | 一种艾司奥美拉唑镁延释制剂及其制备方法 |
WO2024075017A1 (fr) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition de calcification de valve aortique |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
JPH0768125B2 (ja) * | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
-
1993
- 1993-07-09 SE SE19939302395A patent/SE9302395D0/xx unknown
-
1994
- 1994-07-01 HR HR940386A patent/HRP940386B1/xx not_active IP Right Cessation
- 1994-07-01 IL IL11018994A patent/IL110189A0/xx not_active IP Right Cessation
- 1994-07-03 DZ DZ940072A patent/DZ1794A1/fr active
- 1994-07-04 SA SA94150057A patent/SA94150057B1/ar unknown
- 1994-07-06 IS IS4187A patent/IS2034B/is unknown
- 1994-07-07 MA MA23568A patent/MA23258A1/fr unknown
- 1994-07-07 ZA ZA944934A patent/ZA944934B/xx unknown
- 1994-07-07 MY MYPI94001776A patent/MY128809A/en unknown
- 1994-07-07 EG EG40894A patent/EG22373A/xx active
- 1994-07-08 UA UA96010058A patent/UA43342C2/uk unknown
- 1994-07-08 US US08/313,036 patent/US5690960A/en not_active Expired - Lifetime
- 1994-07-08 RU RU96102154/14A patent/RU2138254C9/ru active
- 1994-07-08 YU YU43794A patent/YU49199B/sh unknown
- 1994-07-08 AT AT94921155T patent/ATE231719T1/de active
- 1994-07-08 HU HU9503874A patent/HU226779B1/hu unknown
- 1994-07-08 CA CA002166483A patent/CA2166483C/fr not_active Expired - Lifetime
- 1994-07-08 TN TNTNSN94078A patent/TNSN94078A1/fr unknown
- 1994-07-08 SK SK21-96A patent/SK281105B6/sk not_active IP Right Cessation
- 1994-07-08 CN CN94192734A patent/CN1126946A/zh active Pending
- 1994-07-08 SI SI9430438T patent/SI0706378T1/xx unknown
- 1994-07-08 JP JP50400695A patent/JP3665334B2/ja not_active Expired - Lifetime
- 1994-07-08 DK DK94921155T patent/DK0706378T3/da active
- 1994-07-08 AU AU71982/94A patent/AU681686B2/en not_active Expired
- 1994-07-08 MX MX9405219A patent/MX9405219A/es unknown
- 1994-07-08 KR KR1019960700052A patent/KR100350203B1/ko not_active IP Right Cessation
- 1994-07-08 PL PL94312441A patent/PL175210B1/pl unknown
- 1994-07-08 BR BR9406941A patent/BR9406941A/pt not_active Application Discontinuation
- 1994-07-08 SG SG1996003536A patent/SG52365A1/en unknown
- 1994-07-08 WO PCT/SE1994/000681 patent/WO1995001783A1/fr active IP Right Grant
- 1994-07-08 DE DE69432076T patent/DE69432076T2/de not_active Expired - Lifetime
- 1994-07-08 CZ CZ199670A patent/CZ290323B6/cs not_active IP Right Cessation
- 1994-07-08 EP EP94921155A patent/EP0706378B1/fr not_active Expired - Lifetime
- 1994-07-08 NZ NZ268694A patent/NZ268694A/en not_active IP Right Cessation
- 1994-07-08 ES ES94921155T patent/ES2191682T3/es not_active Expired - Lifetime
- 1994-11-17 EE EE9400419A patent/EE03148B1/xx unknown
-
1996
- 1996-01-05 NO NO19960067A patent/NO315146B1/no not_active IP Right Cessation
- 1996-01-09 FI FI960102A patent/FI114008B/fi not_active IP Right Cessation
-
1998
- 1998-07-17 HK HK98109229A patent/HK1008299A1/xx not_active IP Right Cessation
-
2004
- 2004-01-22 LV LVP-04-07A patent/LV13140B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN94078A1 (fr) | Nouvelle formule pharmaceutique | |
SE8300736D0 (sv) | Novel pharmacologically active compounds | |
HUT50786A (en) | Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components | |
MA23608A1 (fr) | Forme de dosage ii d'unite multiple en comprime | |
ES2188584T3 (es) | Derivados heterociclicos de amina. | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
TNSN97193A1 (fr) | Amides inhibiteurs de secretion de apo b/mtp, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99006A1 (fr) | 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN00232A1 (fr) | Derives de 2,4-diaminopyrimidine nouveaux, et compositions les contenant | |
DK163287A (da) | 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser | |
DE69504509T2 (de) | Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten | |
TNSN98113A1 (fr) | Procede de preparation de composes utiles pour le traitement de la resistance a l'insuline. | |
FR2688405B1 (fr) | Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant. | |
KR960703863A (ko) | 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer) | |
ES2108595A1 (es) | Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion. | |
FI885560A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
TNSN99146A1 (fr) | Derives de 1-heteroaryl-pyrrolidine, -piperidine et - homopiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
SE9103776D0 (sv) | New compounds | |
TNSN00095A1 (fr) | Benzolactames et thioamides cycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN00105A1 (fr) | Derives de 1-trifluoromethyl-4-hydroxy-7-piperidinyl- aminomethylchromane, procede pour leur preparation et compositions pharmaceutiques les contenant | |
FR2585953B1 (fr) | Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede | |
PL323305A1 (en) | Applications of allyl amines | |
FR2515516B1 (fr) | Composition pharmaceutique pour le traitement de la lithiase renale infectee contenant de l'acide propionohydroxamique ou ses sels acceptables en pharmacie | |
ES2062214T3 (es) | Derivados de aminooligohidroxi inhibidores de renina. | |
ES2137665T3 (es) | Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos. |